PAMELA MATTHEWS: Open Payments
NPI 1952343238 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 46 payments from 16 companies in 2025. Trend: 2023 $138 · 2024 $1,733 · 2025 $1,228
Food & beverage: $1,133Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $428 |
| PFIZER INC. | 4 | $162 |
| ABBVIE INC. | 11 | $156 |
| UCB, Inc. | 9 | $150 |
| Amgen Inc. | 4 | $72 |
| Incyte Corporation | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| GENZYME CORPORATION | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $18 |
Products named: TREMFYA, Bimzelx, LITFULO, RINVOQ, SKYRIZI, OTEZLA, CIBINQO, OPZELURA.
Industry payments across KS — which companies pay providers there.
